Concepedia

Deborah DeRyckere

DD

Statistics

Publications

51

Citations

3.2K

H-Index

33

Active since

1992

Affiliations

University of North Carolina at Chapel Hill(Current)

Children's Healthcare of Atlanta

University of Colorado Anschutz Medical Campus

Emory University

University of Colorado Denver

Deborah DeRyckere is an author at University of North Carolina at Chapel Hill specializing in oncology, medicine, and molecular oncology.

Publications per year

1992–2024

51

Publications

51

Structure and Function of Cdc6/Cdc18

Jinyu Liu, Cheryl L. Smith, Deborah DeRyckere et al. · Molecular Cell · 2000 · 229 citations

Life Sciences, Cell Biology, Molecular Biology +10

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 217 citations

Life Sciences, Cancer Biology, Oncology +16

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Rebecca S. Cook, Kristen M. Jacobsen, Anne Wofford et al. · Journal of Clinical Investigation · 2013 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Weihe Zhang, Deborah DeRyckere, Debra M. Hunter et al. · Journal of Medicinal Chemistry · 2014 · 160 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Jennifer Schlegel, Maria J. Sambade, Susan Sather et al. · Journal of Clinical Investigation · 2013 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 51